The complement system in intestinal inflammation and cancer
Open Access
- 1 October 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (19)
Abstract
The complement system has emerged as a critical regulator of intestinal homeostasis, inflammation, and cancer. In this Review, we explore the multifaceted roles of complement in the gastrointestinal tract, highlighting its canonical and noncanonical functions across intestinal epithelial and immune cells. Under homeostatic conditions, intestinal cells produce complement that maintains barrier integrity and modulates local immune responses, but complement dysregulation contributes to intestinal inflammation and promotes colon cancer. We discuss recent clinical and preclinical studies to provide a cohesive overview of how complement-mediated modulation of immune and nonimmune cell functions can protect or exacerbate inflammation and colon cancer development. The complement system plays a dual role in the intestine, with certain components supporting tissue protection and repair and others exacerbating inflammation. Intriguingly, distinct complement pathways modulate colon cancer progression and response to therapy, with novel findings suggesting that the C3a/C3aR axis constrains early tumor development but may limit antitumor immunity. The recent discovery of intracellular complement activation and tissue-specific complement remains vastly underexplored in the context of intestinal inflammation and colon cancer. Collectively, complement functions are context- and cell-type-dependent, acting both as a shield and a sword in intestinal diseases. Future studies dissecting the temporal and spatial dynamics of complement are essential for leveraging its potential as a biomarker and therapeutic in colon cancer.Keywords
This publication has 148 references indexed in Scilit:
- Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide releaseThe Lancet, 1992
- Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.Gut, 1992
- Enhanced Local Production of Complement Components in the Small Intestines of Patients with Crohn's DiseaseNew England Journal of Medicine, 1990
- Epithelial Deposition of Immunoglobulin G1 and Activated Complement (C3b and Terminal Complement Complex) in Ulcerative ColitisGastroenterology, 1990
- A high incidence of C9 deficiency among healthy blood donors in Osaka, JapanInternational Immunology, 1989
- DEFICIENCY OF THE 6TH COMPONENT OF COMPLEMENT AND SUSCEPTIBILITY TO NEISSERIA-MENINGITIDIS INFECTIONS - STUDIES IN 10 FAMILIES AND 5 ISOLATED CASES1987
- Host Defense Against Neisseria meningitidis Requires a Complement-Dependent Bactericidal ActivityScience, 1979
- C3 METABOLISM IN ULCERATIVE-COLITIS AND CROHNS-DISEASE1977
- The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.1976
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTJournal of Experimental Medicine, 1968